TABLE 5.
Logistic regression analysis to assess the relationship between demographic, epidemiological, clinical variables and mortality
| Univariable analysis | Multivariable analysis | |||
| OR (95% CI) | p-value | OR (95% CI) | p-value | |
| Age, years (10-year increase) | 1.82 (1.58–2.09) | <0.0001 | 1.93 (1.60–2.32) | <0.0001 |
| Male (yes versus no) | 2.08 (1.16–3.71) | 0.014 | 2.92 (1.38–6.16) | 0.005 |
| ≥1 comorbidity (yes versus no) | 6.01 (3.21–11.27) | <0.0001 | ||
| Diabetes mellitus (yes versus no) | 2.69 (1.67–4.35) | <0.0001 | ||
| Cardiovascular disease (yes versus no) | 5.12 (3.19–8.22) | <0.0001 | ||
| Chronic respiratory disease (yes versus no) | 3.00 (1.74–5.18) | <0.0001 | ||
| HIV (yes versus no) | 1.48 (0.77–2.87) | 0.241 | ||
| Chronic liver disease (yes versus no) | 1.69 (0.82–3.46) | 0.155 | ||
| Chronic renal disease (yes versus no) | 3.00 (1.74–5.18) | <0.0001 | ||
| Invasive ventilation (yes versus no) | 25.18 (12.64–50.13) | <0.0001 | 28.22 (1.37–64.39) | <0.0001 |
| Active TB (yes versus no) | 1.5 (1.0–2.5) | 0.069 | ||
| Presence of key symptoms (yes versus no) | 49.3 (19.7–123.9) | <0.0001 | ||
| Hospitalisation due to COVID-19 (yes versus no) | 3.54 (1.95–6.41) | <0.0001 | ||
| Duration of hospitalisation (1-day increase) | 0.98 (0.96–1.01) | 0.072 | ||
| Europe (yes versus no) | 1.63 (1.04–2.57) | 0.034 | ||
Multivariable model −2 log likelihood: 301.6, p<0.0001; percentage of cases correctly classified: 91%; area under the curve: 0.89 (0.86–0.91). TB: tuberculosis; COVID-19: coronavirus disease 2019.